semaglutide 2025 Market Size, Share & Trends Report, 2025-2035 September 2024 vs January 2025

Clinical trials primarily focused on individuals with obesity or overweight plus comorbidities

Evidence-based GLP-1 care (semaglutide) with habit coaching for sustainable results

For people who cannot access or afford FDA-approved options, compounded semaglutide represents a calculated trade-off between cost accessibility and maximum regulatory oversight

Please note that canceling your treatment plan in the portal will not cancel any active orders that have already been sent to the pharmacy

Common side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain These side effects are often temporary and may subside as your body adjusts to the medication

GLP-1 Compounding Scrutiny: FDA has issued alerts on compounded semaglutide and tirzepatide, warning against incorrect dosing and use of salt forms not permitted for compounding